prescribing of inhaled corticosteroids for asthma in new zealand

PharmacoEconomics & Outcomes News 286 - 28 Oct 2000 ■ The average doses of inhaled corticosteroids prescribed to primary-care patients with asthma in New Zealand do not reflect drug potency, suggest researchers based in that country. They examined 95 540 prescriptions for inhaled corticosteroids written by 293 general practitioners in Auckland, New Zealand, between November 1995 and June 1998. * The average daily doses prescribed were 747µg for beclomethasone, 1184µg for budesonide and 600µg for fluticasone propionate. The average prescribed daily dose of fluticasone propionate was about 80% of that for beclomethasone, despite the fact that fluticasone propionate is twice as potent as beclomethasone, comment the researchers. * The study was supported in part by Astra Pharmaceuticals, New Zealand. Black PN, et al. Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand. European Journal of Clinical Pharmacology 56: 431-435, Aug 2000 800846756 1 PharmacoEconomics & Outcomes News 28 Oct 2000 No. 286 1173-5503/10/0286-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: vankhanh

Post on 16-Mar-2017

213 views

Category:

Documents

1 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Prescribing of inhaled corticosteroids for asthma in New Zealand

PharmacoEconomics & Outcomes News 286 - 28 Oct 2000

■ The average doses of inhaled corticosteroidsprescribed to primary-care patients with asthma inNew Zealand do not reflect drug potency, suggestresearchers based in that country. They examined 95540 prescriptions for inhaled corticosteroids writtenby 293 general practitioners in Auckland, NewZealand, between November 1995 and June 1998.*The average daily doses prescribed were 747µg forbeclomethasone, 1184µg for budesonide and 600µgfor fluticasone propionate. The average prescribeddaily dose of fluticasone propionate was about 80% ofthat for beclomethasone, despite the fact thatfluticasone propionate is twice as potent asbeclomethasone, comment the researchers.* The study was supported in part by Astra Pharmaceuticals, NewZealand.

Black PN, et al. Differences in the potencies of inhaled steroids are notreflected in the doses prescribed in primary care in New Zealand. EuropeanJournal of Clinical Pharmacology 56: 431-435, Aug 2000 800846756

Intensified Therapy with Inhaled Corticosteroids and Long ... 2018_Intensifi… · Intensified Therapy with Inhaled Corticosteroids and Long-Acting ... Most exacerbations of COPD

Inhaled corticosteroids downregulate the SARS-CoV-2 ... · 13/6/2020 · 1 Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I

Inhaled Corticosteroids in Asthma - KoreaMed · Inhaled Corticosteroids in Asthma I z] ... systemic effects of the drugs were a major obstacle to use them in asthma therapy. A

HIGHLIGHTS OF PRESCRIBING INFORMATION ------------------------ … · 2020-05-01 · and long-acting bronchodilators and inhaled corticosteroids. Following the first 4 doses of DARZALEX

Inhaled drug delivery: A practical guide to prescribing

Systematic review on inhaled corticosteroid monotherapy ... · Continuous therapy with inhaled corticosteroids in COPD is controversially discussed. The aim of this systematic review

Lea Bentur, MD Pediatric Pulmonary Unit Inhaled corticosteroids in preschool asthmatic children. Is it really needed?? OR Can inhaled corticosteroids change

CONTENTS inhaled anti-asthmatic drugs, particularly inhaled corticosteroids, in the treatment of asthma, and outlines their place in guidelines for the treatment of asthma. Remedies

Does the use of inhaled corticosteroids in’asthma benefit …...Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and

Role of Inhaled Corticosteroids in COPD

Inhaled corticosteroids in COPD: the clinical evidence · Inhaled corticosteroids in COPD: the clinical evidence Pierre Ernst1,2, Nathalie Saad1 and Samy Suissa2,3 Affiliations: 1Dept

New FACTORS AFFECTING PULMONARY TARGETING OF INHALED … · 2010. 5. 1. · FACTORS AFFECTING PULMONARY TARGETING OF INHALED CORTICOSTEROIDS By KAI WU A DISSERTATION PRESENTED TO